Analysing the Effect of Empagliflozin on Reduction of Tissue Sodium Content in Patients With Chronic Heart Failure
Clinical trial NCT03128528 · COMPLETED
Trial details
- NCT number
- NCT03128528
- Sponsor
- University of Erlangen-Nürnberg Medical School
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-01
- Primary completion
- 2020-01-31
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.